Cargando…
Immunogenicity of Vi capsular polysaccharide vaccine evaluated for three years in Korea.
The immunogenicity of a single dose of Salmonella typhi(S.typhi) Vi capsular polysaccharide(CPS) vaccine was evaluated before, and at 1, 3, 12, and 36 months after vaccination. Eighty-five adults(20-28 years of age) and sixty-four children(8-16 years of age) received a single dose of 25 micrograms V...
Autores principales: | Kim, Y. R., Yoo, J. H., Hur, J. K., Kang, J. H., Shin, W. S., Kang, M. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Medical Sciences
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054155/ https://www.ncbi.nlm.nih.gov/pubmed/8750055 |
Ejemplares similares
-
Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals
Publicado: (1987) -
Identification, Characterization and Immunogenicity of an O-Antigen Capsular Polysaccharide of Francisella tularensis
por: Apicella, Michael A., et al.
Publicado: (2010) -
Regulation of Vi Capsular Polysaccharide Synthesis in Salmonella enterica Serotype Typhi
por: Santander, Javier M, et al.
Publicado: (2008) -
Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodies
por: Rigsby, Peter, et al.
Publicado: (2020) -
Synthetic Analogs of Streptococcus pneumoniae Capsular Polysaccharides and Immunogenic Activities of Glycoconjugates
por: Gening, M. L., et al.
Publicado: (2021)